These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 39215339)

  • 1. Drug-induced liver injury associated with atypical generation antipsychotics from the FDA Adverse Event Reporting System (FAERS).
    He S; Chen B; Li C
    BMC Pharmacol Toxicol; 2024 Aug; 25(1):59. PubMed ID: 39215339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Safety Signal Assessment of Hospitalization Associated With the Use of Atypical Antipsychotics.
    Yunusa I; Teng C; Karaye IM; Crounse E; Alsahali S; Maleki N
    Front Psychiatry; 2022; 13():917351. PubMed ID: 35733796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced liver injury associated with antiseizure medications from the FDA Adverse Event Reporting System (FAERS).
    Kamitaki BK; Minacapelli CD; Zhang P; Wachuku C; Gupta K; Catalano C; Rustgi V
    Epilepsy Behav; 2021 Apr; 117():107832. PubMed ID: 33626490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced liver injury associated with elexacaftor/tezacaftor/ivacaftor: A pharmacovigilance analysis of the FDA adverse event reporting system (FAERS).
    Shi A; Nguyen H; Kuo CB; Beringer PM
    J Cyst Fibros; 2024 May; 23(3):566-572. PubMed ID: 38233246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacovigilance study on drug-induced liver injury associated with antibody-drug conjugates (ADCs) based on the food and drug administration adverse event reporting system.
    Sun C; Yang X; Tang L; Chen J
    Expert Opin Drug Saf; 2024 Aug; 23(8):1049-1060. PubMed ID: 37898875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacovigilance study of the association between antipsychotic drugs and venous thromboembolism based on Food and Drug Administration Adverse Event Reporting System data.
    Yan Y; Wang L; Yuan Y; Xu J; Chen Y; Wu B
    Expert Opin Drug Saf; 2024 Jun; 23(6):771-776. PubMed ID: 37615268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system.
    Raschi E; Poluzzi E; Koci A; Salvo F; Pariente A; Biselli M; Moretti U; Moore N; De Ponti F
    Br J Clin Pharmacol; 2015 Aug; 80(2):285-93. PubMed ID: 25689417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacovigilance study of the association between tetracyclines and hepatotoxicity based on Food and Drug Administration adverse event reporting system data.
    Wei C; Liu Y; Jiang A; Wu B
    Int J Clin Pharm; 2022 Jun; 44(3):709-716. PubMed ID: 35364753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse event profiles of drug-induced liver injury caused by antidepressant drugs: a disproportionality analysis.
    Jiang A; Wei C; Zhu W; Wu F; Wu B
    Ther Adv Drug Saf; 2024; 15():20420986241244585. PubMed ID: 38715707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling cumulative proportional reporting ratios of drug-induced liver injury in the FDA Adverse Event Reporting System (FAERS) database.
    Brinker AD; Lyndly J; Tonning J; Moeny D; Levine JG; Avigan MI
    Drug Saf; 2013 Dec; 36(12):1169-78. PubMed ID: 24178291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
    Welch HK; Kellum JA; Kane-Gill SL
    Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse event profiles of ifosfamide-induced encephalopathy analyzed using the Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databases.
    Shimada K; Hasegawa S; Nakao S; Mukai R; Matsumoto K; Tanaka M; Uranishi H; Masuta M; Nishida S; Shimizu S; Hayashi Y; Suzuki A; Nakamura M
    Cancer Chemother Pharmacol; 2019 Nov; 84(5):1097-1105. PubMed ID: 31502115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatotoxicity reports in the FDA adverse event reporting system database: A comparison of drugs that cause injury
    Rana P; Aleo MD; Wen X; Kogut S
    Acta Pharm Sin B; 2021 Dec; 11(12):3857-3868. PubMed ID: 35024312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of acute kidney injury related to small-molecule protein kinase inhibitors using the FDA adverse event reporting system.
    Fan Q; Ma J; Zhang B; Li Q; Liu F; Zhao B
    Cancer Chemother Pharmacol; 2020 Nov; 86(5):655-662. PubMed ID: 33001273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between ketamine and esketamine with alcohol and substance misuse: Reports to the Food and Drug Administration adverse event reporting system (FAERS).
    Kwan ATH; Rosenblat JD; Mansur RB; Teopiz KM; McIntyre RS
    J Affect Disord; 2024 Sep; 360():421-426. PubMed ID: 38795777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical antipsychotic drugs and diabetes mellitus in the US Food and Drug Administration Adverse Event database: a systematic Bayesian signal detection analysis.
    Baker RA; Pikalov A; Tran QV; Kremenets T; Arani RB; Doraiswamy PM
    Psychopharmacol Bull; 2009; 42(1):11-31. PubMed ID: 19204649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).
    DuMouchel W; Fram D; Yang X; Mahmoud RA; Grogg AL; Engelhart L; Ramaswamy K
    Ann Clin Psychiatry; 2008; 20(1):21-31. PubMed ID: 18297583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced liver injury associated with lopinavir-ritonavir in patients with COVID-19: a disproportionality analysis of U.S. food and drug administration adverse event reporting system (FAERS) data.
    Tang H; Zhou L; Li X; Kinlaw AC; Yang JY; Moon AM; Barnes EL; Wang T
    Int J Clin Pharm; 2021 Aug; 43(4):1116-1122. PubMed ID: 34328585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of eye disorders induced by atypical antipsychotics: a real-world study from 2016 to 2022 based on Food and Drug Administration Adverse Event Reporting System.
    Mu C; Chen L
    Front Psychiatry; 2024; 15():1322939. PubMed ID: 39156610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe.
    Raschi E; Poluzzi E; Godman B; Koci A; Moretti U; Kalaba M; Bennie M; Barbui C; Wettermark B; Sturkenboom M; De Ponti F
    PLoS One; 2013; 8(11):e81208. PubMed ID: 24278396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.